• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Expert Rev Pharmacoecon Outcomes Res . Secondary healthcare resource utilization and related costs associated with influenza-related hospital admiss

tetano

Editor, Senior Moderator
Expert Rev Pharmacoecon Outcomes Res


. 2024 Nov 14:1-13.
doi: 10.1080/14737167.2024.2427307. Online ahead of print. Secondary healthcare resource utilization and related costs associated with influenza-related hospital admissions in adult patients, England 2016 - 2020

Caroline de Courville[SUP] 1 [/SUP], Hélène Bricout[SUP] 2 [/SUP], Fabián P Alvarez[SUP] 1 [/SUP], Jasper Clouting[SUP] 3 [/SUP], Sonya Patel[SUP] 4 [/SUP], Hafsa Mohamed[SUP] 4 [/SUP], Shreena Giblin[SUP] 3 [/SUP], Briana Coles[SUP] 4 [/SUP]



Affiliations
Abstract

Introduction: This study aims to investigate healthcare resource utilization and related costs for influenza virus infections in adults admitted into secondary care in England across four influenza seasons.
Methods: This study includes all influenza admissions from the Hospital Episode Statistics database (HES) across England, September 2016 to March 2020. Descriptive analyses and comparative modeling techniques were used to assess the impact of influenza on risk groups of interest.
Results: Influenza admissions were estimated to cost £401 M. Average admission costs were heavily impacted by age and comorbid status, with comorbid patients representing 91% of costs. Additionally, patients with comorbidities treated in secondary care cost twice as much as non-comorbid patients, after adjusting for age and gender. Comorbid patients also had increased length of stay (LOS) and admissions to ICU, with patients' LOS being a core contributing factor to higher costs.
Conclusion: The study documents the substantial burden of influenza in England, emphasizing the impact of age and comorbid status on healthcare resource utilization (HCRU) and related costs. The data presented offers critical information to healthcare systems evaluating new strategies to alleviate the winter pressures on the NHS; highlighting the need to implement vaccination campaigns with enhanced vaccinations and increased vaccine coverage.

Keywords: Influenza; NHS; burden; costs; healthcare resource utilization.

 
Back
Top Bottom